We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Researchers to Benefit from New Inverted Microscopes

By LabMedica International staff writers
Posted on 09 Nov 2016
Print article
Image: The Axio Observer family consists of three stable and modular microscope stands for flexible and efficient imaging (Photo courtesy of ZEISS).
Image: The Axio Observer family consists of three stable and modular microscope stands for flexible and efficient imaging (Photo courtesy of ZEISS).
A new inverted microscope platform with enhanced optical characteristics and extended water immersion capability is now available for biotech and other life science researchers.

The highly regarded microscope manufacturer ZEISS (Jena, Germany) has introduced the Axio Observer line of inverted microscopes for life science research. The Axio Observer family comprises three stable and modular microscope stands for flexible and efficient imaging.

Axio Observer combines the proven quality of ZEISS optics with new automation features, allowing researchers to perform demanding multimodal imaging of living and fixed specimens. Among these features is Autocorr, a technology that allows adaptation of immersion objectives to varying sample carriers and imaging conditions.

The new Autoimmersion option that builds up and maintains stable water immersion without traditional problems such as evaporation or air bubbles is compatible with multiple water immersion objectives in the nosepiece. It uses a powerful piezo-electric pump to bring water from a small tank to a nozzle in the center of the objective turret. With a single click just the right amount of water is applied to the active immersion objective. This provides better contrast and resolution, more efficient light collection, and increased sensitivity.
Definite Focus.2 is a novel hardware focus feature that automatically compensates for focus drift and enables long-term time-lapse imaging and demanding multi-position experiments. Axio Observer can be combined with the new multicolor LED light source Colibri 7 that delivers up to seven excitation wavelengths. This light source, in combination with new Virtual Filter technology, enables researchers to perform ultrafast fluorescence imaging with high spectral flexibility.

The Axio Observer platform is controlled by ZEN imaging software. The current release 2.3 integrates all new features seamlessly and offers convenient experiment setup with dedicated wizards, large-data acquisition, and data processing in two and three-dimensions, including a powerful graphics card-enabled three-dimensional deconvolution. Data can easily be exported to a multitude of file formats and third-party software.

Related Links:
ZEISS

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.